Schonfeld Strategic Advisors’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.02M | Buy |
42,899
+14,082
| +49% | +$662K | 0.01% | 900 |
|
2025
Q1 | $1.27M | Sell |
28,817
-165,226
| -85% | -$7.29M | 0.01% | 1075 |
|
2024
Q4 | $7.01M | Sell |
194,043
-5,242
| -3% | -$189K | 0.04% | 371 |
|
2024
Q3 | $6.39M | Buy |
199,285
+59,179
| +42% | +$1.9M | 0.04% | 369 |
|
2024
Q2 | $5.28M | Sell |
140,106
-102,067
| -42% | -$3.84M | 0.03% | 462 |
|
2024
Q1 | $11.9M | Sell |
242,173
-224,284
| -48% | -$11M | 0.08% | 281 |
|
2023
Q4 | $17M | Buy |
+466,457
| New | +$17M | 0.11% | 173 |
|
2023
Q1 | – | Sell |
-10,200
| Closed | -$265K | – | 2522 |
|
2022
Q4 | $265K | Sell |
10,200
-25,942
| -72% | -$675K | ﹤0.01% | 1828 |
|
2022
Q3 | $1.03M | Buy |
36,142
+1,242
| +4% | +$35.5K | 0.01% | 1223 |
|
2022
Q2 | $859K | Buy |
+34,900
| New | +$859K | 0.01% | 1015 |
|